About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Prltm1Hmn
targeted mutation 1, Nelson D Horseman
MGI:1934021
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Prltm1Hmn/Prltm1Hmn involves: 129S2/SvPas MGI:2659187


Genotype
MGI:2659187
hm1
Allelic
Composition
Prltm1Hmn/Prltm1Hmn
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prltm1Hmn mutation (4 available); any Prl mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• surprisingly, male homozygotes show normal plasma testosterone levels despite reduced LH levels
• in vitro, both basal and LH-stimulated testosterone release remains unaffected
• at 6-8 weeks of age, female homozygotes display hypertrophic pituitaries with abnormal cell boundaries
• many cells have increased cytoplasmic volumes with granular accumulations of an N-terminal peptide encoded by the disrupted gene
• although pituitary GH cells appear to be normal, they are largely absent in areas of hyperplasia at 3 months and severely displaced in adenomatous sections at 15 months of age
• at 6 weeks of age, homozygotes show a slight decrease in the volume of acidophilic cells in the anterior pituitary gland
• at 15-18 months of age, all aged female homozygotes show obviously enlarged pituitaries, consistent with the development of adenomas and vascular congestion (J:79661)
• male homozygotes display strikingly enlarged pituitary glands (J:83246)
• in male homozygotes, pituitary weight is increased by ~100% relative to that in wild-type males
• at 6 weeks of age, female homozygotes display pituitary hyperplasia
• at 6-8 weeks of age, female homozygotes display hypertrophic pituitaries with abnormal cell boundaries
• at 6 weeks of age, mutant mammary glands show only some mild signs of hyperplasia and neutrophil infiltration
• female homozygotes display impaired pre-lactogenic mammary gland development
• in adult virgin female homozygotes, the ductal system comprises an extended branching network but is devoid of terminal and lateral lobulation
• at 5 months of age, mutant mammary ducts terminate as tapered tubes, blunt-ending tubes, or terminal end buds
• however, no increase in the number of branches is observed during mammary development
• the weights of mutant ventral prostates are significantly reduced relative to those in wild-type mice (12.3 +/- 0.94 mg versus 17.1 +/- 3.14 mg, respectively)
• however, the weights of coagulating glands are normal
• the weights of mutant seminal vesicles (full) are significantly reduced relative to those in wild-type mice (282 +/- 16 mg versus 322 +/- 32 mg, respectively)
• however, no significant differences in body weight or in the weights of testes or epididymides are observed
• at 8 months of age or later, all aged female homozygotes display large hyperemic pituitary adenomas composed of monomorphic, weakly eosinophilic cells with large perinuclear cytoplasmic inclusions
• pituitary tumors synthesize the truncated peptide, suggesting that the tumors arise from the lactotroph lineage
• pituitary cells cultured from 8-month-old or older homozygotes grow as colonies in soft agar whereas those from 3-month-old mice remain as single cells, suggesting that anchorage-independent growth of tumor cells is acquired between 3 and 8 months of age
• growth and transformation of pseudolactotrophs appears to be accelerated in females compared with males
• treatment of 8-month-old female homozygotes with bromocriptin (a dopamine agonist) reduces mean pituitary weight by 66% and results in tumor regression and cell shrinkage, not observed in untreated or vehicle-treated homozygotes
• no pathologies or lesions other than pituitary adenomas are observed
• in vitro, mutant pituitaries release significantly less LH and FSH when calculated on a weight basis; however, no differences are observed when calculated on a per pituitary basis

homeostasis/metabolism
• at 4 months of age, female homozygotes display significantly lower serum estrogen levels than wild-type controls (41.2 pg/ml versus 73.1 pg/ml, respectively)
• at 4 months of age, female homozygotes display significantly lower serum 17beta-estradiol levels than wild-type controls (0.15 nM versus 0.27 nM, respectively)
• dopamine levels in the median eminence are significantly reduced relative to those in wild-type controls
• however, dopamine content in the medial basal hypothalamus and anterior hypothalamus remains normal
• no significant differences in hypothalamic norepinephrine levels are observed in these regions
• at the time of death, the contents of FSH per mg pituitary are markedly reduced relative to those in wild-type mice; however, when FSH contents are expressed on a per pituitary basis, the difference is not statistically significant
• at the time of death, the contents of LH per mg pituitary are markedly reduced relative to those in wild-type mice; however, when LH contents are expressed on a per pituitary basis, the difference is not statistically significant
• male homozygotes show significantly lower plasma LH levels than wild-type males (1.17 +/- 0.19 ng/ml versus 1.75 +/- 0.24 ng/ml, respectively)
• in contrast, plasma testosterone levels remain unaffected in mutant males
• no prolactin bioactivity is detected in mutant pituitary extracts (J:45243)
• at the time of death, no prolactin is detectable in mutant pituitary homogenates (J:83246)
• no prolactin is detectable in incubation medium with pituitaries from male mutants (J:83246)

reproductive system
• the weights of mutant ventral prostates are significantly reduced relative to those in wild-type mice (12.3 +/- 0.94 mg versus 17.1 +/- 3.14 mg, respectively)
• however, the weights of coagulating glands are normal
• the weights of mutant seminal vesicles (full) are significantly reduced relative to those in wild-type mice (282 +/- 16 mg versus 322 +/- 32 mg, respectively)
• however, no significant differences in body weight or in the weights of testes or epididymides are observed
• female homozygotes display highly irregular estrous cycles with multiple days of proestus and/or multiple days of estrus
• no consistent pattern of cycling is established in individual mutant females
• unlike wild-type females, which have only a single estrus day in each cycle, mutant females can have cycles with multiple days of estrus
• unlike wild-type females, which have only a single proestrus day in each cycle, mutant females can have cycles with multiple days of proestrus
• mutant estous cycles can be longer than the normal 4-5 day cycle
• mutant estous cycles can be shorter than the normal 4-5 day cycle
• female homozygotes ovulate normal numbers of eggs which can be fertilized but fail to progress to implantation
• female homozygotes are completely infertile due to an implantation defect
• in contrast, male homozygotes are fully fertile and produce normal litter sizes

nervous system
• at 6-8 weeks of age, female homozygotes display hypertrophic pituitaries with abnormal cell boundaries
• many cells have increased cytoplasmic volumes with granular accumulations of an N-terminal peptide encoded by the disrupted gene
• although pituitary GH cells appear to be normal, they are largely absent in areas of hyperplasia at 3 months and severely displaced in adenomatous sections at 15 months of age
• at 6 weeks of age, homozygotes show a slight decrease in the volume of acidophilic cells in the anterior pituitary gland
• at 15-18 months of age, all aged female homozygotes show obviously enlarged pituitaries, consistent with the development of adenomas and vascular congestion (J:79661)
• male homozygotes display strikingly enlarged pituitary glands (J:83246)
• in male homozygotes, pituitary weight is increased by ~100% relative to that in wild-type males
• at 6 weeks of age, female homozygotes display pituitary hyperplasia
• at 6-8 weeks of age, female homozygotes display hypertrophic pituitaries with abnormal cell boundaries
• at 8 months of age or later, all aged female homozygotes display large hyperemic pituitary adenomas composed of monomorphic, weakly eosinophilic cells with large perinuclear cytoplasmic inclusions
• pituitary tumors synthesize the truncated peptide, suggesting that the tumors arise from the lactotroph lineage
• pituitary cells cultured from 8-month-old or older homozygotes grow as colonies in soft agar whereas those from 3-month-old mice remain as single cells, suggesting that anchorage-independent growth of tumor cells is acquired between 3 and 8 months of age
• growth and transformation of pseudolactotrophs appears to be accelerated in females compared with males
• treatment of 8-month-old female homozygotes with bromocriptin (a dopamine agonist) reduces mean pituitary weight by 66% and results in tumor regression and cell shrinkage, not observed in untreated or vehicle-treated homozygotes
• no pathologies or lesions other than pituitary adenomas are observed
• in vitro, mutant pituitaries release significantly less LH and FSH when calculated on a weight basis; however, no differences are observed when calculated on a per pituitary basis

neoplasm
• at 8 months of age or later, all aged female homozygotes display large hyperemic pituitary adenomas composed of monomorphic, weakly eosinophilic cells with large perinuclear cytoplasmic inclusions
• pituitary tumors synthesize the truncated peptide, suggesting that the tumors arise from the lactotroph lineage
• pituitary cells cultured from 8-month-old or older homozygotes grow as colonies in soft agar whereas those from 3-month-old mice remain as single cells, suggesting that anchorage-independent growth of tumor cells is acquired between 3 and 8 months of age
• growth and transformation of pseudolactotrophs appears to be accelerated in females compared with males
• treatment of 8-month-old female homozygotes with bromocriptin (a dopamine agonist) reduces mean pituitary weight by 66% and results in tumor regression and cell shrinkage, not observed in untreated or vehicle-treated homozygotes
• no pathologies or lesions other than pituitary adenomas are observed

immune system
N
• homozygotes display normal bone marrow B lymphopoiesis and myelopoiesis relative to heterozygous control littermates
• no differences in thymus cellularity or frequency of thymocyte subpopulations are observed
• a normal frequency of B and T cells is observed in the spleen and lymph nodes

behavior/neurological
N
• at 8 weeks of age, nulliparous female homozygotes display normal spontaneous maternal behavior (pup retrieval and crouching) toward foster pups

liver/biliary system
• the weight of mutant livers is significantly reduced relative to that in wild-type mice (1.51 +/- 0.044 g versus 1.72 +/- 0.085 g, respectively)
• however, no significant differences in the weights of the spleen or adrenals are observed

integument
• at 6 weeks of age, mutant mammary glands show only some mild signs of hyperplasia and neutrophil infiltration
• female homozygotes display impaired pre-lactogenic mammary gland development
• in adult virgin female homozygotes, the ductal system comprises an extended branching network but is devoid of terminal and lateral lobulation
• at 5 months of age, mutant mammary ducts terminate as tapered tubes, blunt-ending tubes, or terminal end buds
• however, no increase in the number of branches is observed during mammary development





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory